These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2786039)

  • 1. Decreased number and function of antigen-presenting cells in the skin following application of irritant agents: relevance for skin cancer?
    Lisby S; Baadsgaard O; Cooper KD; Vejlsgaard GL
    J Invest Dermatol; 1989 Jun; 92(6):842-7. PubMed ID: 2786039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen-presenting OKM5+ melanophages appear in human epidermis after ultraviolet radiation.
    Cooper KD; Neises GR; Katz SI
    J Invest Dermatol; 1986 Apr; 86(4):363-70. PubMed ID: 2943821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous T-cell lymphoma lesional epidermal cells activate autologous CD4+ T lymphocytes: involvement of both CD1+OKM5+ and CD1+OKM5- antigen-presenting cells.
    Hansen ER; Baadsgaard O; Lisby S; Cooper KD; Thomsen K; Vejlsgaard GL
    J Invest Dermatol; 1990 Apr; 94(4):485-91. PubMed ID: 1968933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of OKM5 antigen on epidermal cells in mycosis fungoides plaque stage.
    Lisby S; Baadsgaard O; Cooper KD; Thomsen K; Wantzin GR
    J Invest Dermatol; 1988 May; 90(5):716-9. PubMed ID: 2452212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen-presenting activity of non-Langerhans epidermal cells in contact hypersensitivity reactions.
    Baadsgaard O; Lisby S; Avnstorp C; Clemmensen O; Lange-Vejlsgaard G
    Scand J Immunol; 1990 Sep; 32(3):217-24. PubMed ID: 1698306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of cyclosporine A inhibition of antigen-presenting activity in uninvolved and lesional psoriatic epidermis.
    Cooper KD; Baadsgaard O; Ellis CN; Duell E; Voorhees JJ
    J Invest Dermatol; 1990 May; 94(5):649-56. PubMed ID: 2324521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential patterns of epidermal leukocyte infiltration in patch test reactions to structurally unrelated chemical irritants.
    Willis CM; Stephens CJ; Wilkinson JD
    J Invest Dermatol; 1993 Sep; 101(3):364-70. PubMed ID: 8370975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometrically-sorted residual HLA-DR+T6+ Langerhans cells in topical steroid-treated human skin express normal amounts of HLA-DR and CD1a/T6 antigens and exhibit normal alloantigen-presenting capacity.
    Ashworth J; Kahan MC; Breathnach SM
    J Invest Dermatol; 1989 Feb; 92(2):258-62. PubMed ID: 2783952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psoriatic epidermal cells demonstrate increased numbers and function of non-Langerhans antigen-presenting cells.
    Baadsgaard O; Gupta AK; Taylor RS; Ellis CN; Voorhees JJ; Cooper KD
    J Invest Dermatol; 1989 Feb; 92(2):190-5. PubMed ID: 2645367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increases in human epidermal DR+CD1+, DR+CD1-CD36+, and DR-CD3+ cells in allergic versus irritant patch test responses.
    Gerberick GF; Rheins LA; Ryan CA; Ridder GM; Haren M; Miller C; Oelrich DM; von Bargen E
    J Invest Dermatol; 1994 Oct; 103(4):524-9. PubMed ID: 7523531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of topical corticosteroid therapy on Langerhans cell antigen presenting function in human skin.
    Ashworth J; Booker J; Breathnach SM
    Br J Dermatol; 1988 Apr; 118(4):457-69. PubMed ID: 3288268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotype, ultrastructure, and function of CD1+DR+ epidermal cells that express CD36 (OKM5) in cutaneous T-cell lymphoma.
    Lisby S; Baadsgaard O; Cooper KD; Hansen ER; Mehregan D; Thomsen K; Allen E; Lange Vejlsgaard G
    Scand J Immunol; 1990 Aug; 32(2):111-9. PubMed ID: 1697095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic aspects of acute cutaneous graft-versus-host disease: decreased density and antigen-presenting function of Ia+ Langerhans cells and absent antigen-presenting capacity of Ia+ keratinocytes.
    Breathnach SM; Shimada S; Kovac Z; Katz SI
    J Invest Dermatol; 1986 Mar; 86(3):226-34. PubMed ID: 2427602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoic acid upregulates human Langerhans cell antigen presentation and surface expression of HLA-DR and CD11c, a beta 2 integrin critically involved in T-cell activation.
    Meunier L; Bohjanen K; Voorhees JJ; Cooper KD
    J Invest Dermatol; 1994 Dec; 103(6):775-9. PubMed ID: 7798614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UVB and UVC, but not UVA, potently induce the appearance of T6- DR+ antigen-presenting cells in human epidermis.
    Baadsgaard O; Wulf HC; Wantzin GL; Cooper KD
    J Invest Dermatol; 1987 Jul; 89(1):113-8. PubMed ID: 3598201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The autologous mixed epidermal cell-T lymphocyte reaction is elevated in psoriasis: a crucial role for epidermal HLA-DR+/CD1a- antigen-presenting cells.
    Prens EP; Benne K; van Joost T; Benner R
    J Invest Dermatol; 1991 Jun; 96(6):880-7. PubMed ID: 1710638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PUVA therapy decreases HLA-DR+ CDIa+ Langerhans cells and epidermal cell antigen-presenting capacity in human skin, but flow cytometrically-sorted residual HLA-DR+ CDIa+ Langerhans cells exhibit normal alloantigen-presenting function.
    Ashworth J; Kahan MC; Breathnach SM
    Br J Dermatol; 1989 Mar; 120(3):329-39. PubMed ID: 2469456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose response and time course for induction of T6- DR+ human epidermal antigen-presenting cells by in vivo ultraviolet A, B, and C irradiation.
    Baadsgaard O; Cooper KD; Lisby S; Wulf HC; Wantzin GL
    J Am Acad Dermatol; 1987 Nov; 17(5 Pt 1):792-800. PubMed ID: 3500191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell response to purified protein derivative after removal of Langerhans' cells from epidermal cell suspensions containing keratinocytes expressing class II transplantation antigens.
    Tjernlund U; Scheynius A; Johansson C; Hagforsen E; Nilsson H
    Scand J Immunol; 1988 Dec; 28(6):667-73. PubMed ID: 3266023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mixed epidermal cell-lymphocyte reaction. II. Epidermal Langerhans cells are responsible for the enhanced allogeneic lymphocyte-stimulating capacity of normal human epidermal cell suspensions.
    Sontheimer RD
    J Invest Dermatol; 1985 Jul; 85(1 Suppl):21s-26s. PubMed ID: 3159806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.